New Mexico Educational Retirement Board lowered its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 32,962 shares of the medical research company’s stock after selling 600 shares during the quarter. New Mexico Educational Retirement Board’s holdings in Thermo Fisher Scientific were worth $9,680,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its position in shares of Thermo Fisher Scientific by 0.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,706,326 shares of the medical research company’s stock worth $605,651,000 after buying an additional 17,860 shares in the last quarter. Meeder Asset Management Inc. raised its position in Thermo Fisher Scientific by 73.2% during the first quarter. Meeder Asset Management Inc. now owns 1,237 shares of the medical research company’s stock worth $338,000 after acquiring an additional 523 shares during the period. Pennsylvania Trust Co grew its holdings in shares of Thermo Fisher Scientific by 38.1% during the first quarter. Pennsylvania Trust Co now owns 58,862 shares of the medical research company’s stock worth $16,112,000 after buying an additional 16,246 shares in the last quarter. Baxter Bros Inc. grew its holdings in shares of Thermo Fisher Scientific by 2.2% during the first quarter. Baxter Bros Inc. now owns 29,600 shares of the medical research company’s stock worth $8,102,000 after buying an additional 630 shares in the last quarter. Finally, Winslow Evans & Crocker Inc. grew its holdings in shares of Thermo Fisher Scientific by 2.8% during the first quarter. Winslow Evans & Crocker Inc. now owns 17,298 shares of the medical research company’s stock worth $4,736,000 after buying an additional 470 shares in the last quarter. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have recently issued reports on TMO shares. Needham & Company LLC upped their target price on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a report on Thursday, July 25th. BTIG Research raised their target price on shares of Thermo Fisher Scientific to $320.00 and gave the stock a “buy” rating in a research report on Thursday, May 23rd. Argus raised their target price on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Wolfe Research assumed coverage on shares of Thermo Fisher Scientific in a research report on Thursday, May 30th. They issued an “outperform” rating on the stock. Finally, Barclays set a $330.00 price objective on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Monday, July 15th. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Thermo Fisher Scientific presently has an average rating of “Buy” and an average price target of $303.17.

In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total value of $670,725.00. Following the transaction, the chief financial officer now directly owns 40,029 shares in the company, valued at $10,739,380.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the completion of the transaction, the chief executive officer now owns 342,193 shares in the company, valued at $97,466,832.19. The disclosure for this sale can be found here. Insiders sold 52,775 shares of company stock worth $14,986,676 over the last quarter. Insiders own 0.45% of the company’s stock.

NYSE:TMO traded up $2.27 during trading hours on Wednesday, hitting $278.46. 32,855 shares of the company were exchanged, compared to its average volume of 1,574,825. The stock has a market capitalization of $110.59 billion, a price-to-earnings ratio of 25.00, a price-to-earnings-growth ratio of 1.81 and a beta of 1.11. The company has a current ratio of 1.49, a quick ratio of 1.07 and a debt-to-equity ratio of 0.58. Thermo Fisher Scientific Inc. has a one year low of $208.34 and a one year high of $305.45. The company has a fifty day simple moving average of $285.71 and a 200 day simple moving average of $272.38.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 24th. The medical research company reported $3.04 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The firm had revenue of $6.32 billion for the quarter, compared to analysts’ expectations of $6.31 billion. During the same quarter last year, the firm earned $2.75 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. Equities research analysts predict that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, September 17th will be given a $0.19 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $0.76 annualized dividend and a yield of 0.27%. Thermo Fisher Scientific’s payout ratio is presently 6.83%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Moving Average – How it Helps Investors in Stock Selection

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.